Biogen and Roche are funding a multiple sclerosis trial in Canada.
On January 31st, 2023. See this statement in context.
On January 31st, 2023. See this statement in context.
January 31st, 2023 / 11:40 a.m.
Executive Director, Canadian Brain Research Strategy
Biogen and Roche are funding a multiple sclerosis trial in Canada.
See context to find out what was said next.